Cargando…

Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension

Detalles Bibliográficos
Autores principales:	Simpson, Catherine E., Hassoun, Paul M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875890/ https://www.ncbi.nlm.nih.gov/pubmed/35452380 http://dx.doi.org/10.1164/rccm.202203-0537ED

Ejemplares similares

Myocardial Fibrosis as a Potential Maladaptive Feature of Right Ventricle Remodeling in Pulmonary Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2019)

Hit Early and Hit Hard in Pulmonary Arterial Hypertension? Not So Fast!
por: Hassoun, Paul M., et al.
Publicado: (2021)

When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
por: Niedermeyer, Shannon, et al.
Publicado: (2023)

Nuclear worker studies: promise and pitfalls
por: Wakeford, R
Publicado: (2014)

Phenotyping pulmonary hypertension in systemic sclerosis: a moving target
por: Mercurio, Valentina, et al.
Publicado: (2018)

Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

Multiomics and Multiancestry Approaches: Key Steps to Untangling the Web of Chronic Obstructive Pulmonary Disease Pathogenesis
por: Radder, Josiah E., et al.
Publicado: (2023)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases
por: Boueiz, Adel, et al.
Publicado: (2014)

Genetic testing for rare pediatric lung disorders: The promise and the pitfalls
por: Nogee, Lawrence M.
Publicado: (2020)

Promise and pitfalls in the application of big data to occupational and environmental health
por: Stieb, David M., et al.
Publicado: (2017)

Entering the era of precision medicine through multiomics approach
por: Fujio, Keishi
Publicado: (2022)

Significance of the multiomics approach to elucidate disease mechanisms in humans
por: Fujio, Keishi
Publicado: (2022)

Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations
por: Swinnen, Katleen, et al.
Publicado: (2019)

Clinical features of pulmonary arterial hypertension associated with systemic sclerosis
por: Tuhy, Tijana, et al.
Publicado: (2023)

Towards evidence-based staffing: the promise and pitfalls of patient-to-intensivist ratios
por: Kerlin, Meeta Prasad, et al.
Publicado: (2022)

Multiomics and Health: A Holistic Approach to Better Understand the Role of the Microbiome
por: Toranzos, Gary A., et al.
Publicado: (2021)

Multi‐Beat Right Ventricular‐Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension
por: Hsu, Steven, et al.
Publicado: (2020)

Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography
por: Mercurio, Valentina, et al.
Publicado: (2022)

What is pulmonary arterial hypertension?
por: Rich, Stuart
Publicado: (2012)

The revolution of pulmonary arterial hypertension
por: Harari, Sergio
Publicado: (2016)

Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2019)

A novel approach to perioperative risk assessment for patients with pulmonary hypertension
por: Hassan, Hussein J., et al.
Publicado: (2021)

Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension
por: Naranjo, Mario, et al.
Publicado: (2022)

Promise and pitfalls of the Immunochip
por: Cortes, Adrian, et al.
Publicado: (2011)

The Promise and Pitfalls of Prophages
por: McKerral, Jody C., et al.
Publicado: (2023)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Multiomics kaleidoscope to visualize cancer hallmarks
por: Zhou, Shengtao
Publicado: (2020)

Inhibiting Jak2 Ameliorates Pulmonary Hypertension: Fulfilling the Promise of Precision Medicine
por: Leopold, Jane A.
Publicado: (2021)

Early Detection of Pulmonary Vascular Dysfunction in Neonatal Bronchopulmonary Dysplasia
por: Hassoun, Paul M.
Publicado: (2020)

Promise and Pitfalls of Animal Models of Schizophrenia
por: Feifel, David, et al.
Publicado: (2010)

Vagal Nerve Stimulation for Pulmonary Hypertension: Some Promise, Some Skepticism
por: Ntokou, Aglaia, et al.
Publicado: (2018)

Pulmonary arterial hypertension in scleroderma: care gaps in screening
por: Pope, Janet E.
Publicado: (2017)

Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls
por: Farhat, Nesrine, et al.
Publicado: (2019)

The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension
por: Ormiston, Mark L., et al.
Publicado: (2015)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

A Plot TWIST in Pulmonary Arterial Hypertension
por: Misner, Kevin, et al.
Publicado: (2020)

Deconstructing the Melting Pot in Pulmonary Arterial Hypertension
por: Austin, Eric D., et al.
Publicado: (2020)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

New horizons in pulmonary arterial hypertension management
por: McLaughlin, Vallerie, et al.
Publicado: (2014)

Quality of life in pulmonary arterial hypertension
por: Post, M.C., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_urvaugbun2ks82hfll404ttcbk